Imed Infinity Medical-Limited Partnership (TLV:IMED)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
110.80
0.00 (0.00%)
May 11, 2026, 3:58 PM IDT
Market Cap4.47M +60.1%
Revenue (ttm)720.49K +451.2%
Net Income-612.10K
EPS-0.15
Shares Out4.04M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume7,098
Average Volume16,429
Open110.80
Previous Close110.80
Day's Range110.80 - 110.80
52-Week Range105.00 - 192.00
Beta0.25
RSI42.46
Earnings DateAug 21, 2026

About TLV:IMED

Imed Infinity Medical-Limited Partnership engages in research and development and invests in projects in the medical field in Israel. The company’s products include Genoox, a platform for gathering genetic data; biobeat medical smartmonitoring, which provides wireless patient monitoring solutions for both clinical and at-home use; Polaris Quantum Biotech, a system for the computerized design of drugs using quantum computers; and Cynerio, which focuses on ensuring patient safety and data protection by securing the connected medical device ecosys... [Read more]

Sector Healthcare
Founded 2020
Employees 80
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol IMED
Full Company Profile

Financial Performance

In 2025, TLV:IMED's revenue was $226,000, an increase of 451.22% compared to the previous year's $41,000. Losses were -$192,000, -66.61% less than in 2024.

Financial numbers in USD Financial Statements